Navigation Links
JumpStart Invests in Tursiop Technologies
Date:6/19/2008

CLEVELAND, June 19 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the growth of innovative early-stage businesses and ideas, has announced an investment commitment of $350,000 in Cleveland-based Tursiop Technologies, LLC. The JumpStart investment is part of a recently closed investment round that included $1 million from RMS Management of Cleveland, OH.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/CLJUMPSTARTLOGO )

Tursiop is developing a novel nanomaterial-based coil for magnetic resonance scanners. This new type of coil will bring fundamental change to the MRI market through its improved image quality, compared to conventional coil technologies. Targeting a projected billion dollar market by 2012, Tursiop has already built, tested, and generated images with several prototype coils. These coils have outperformed conventional coils and the Tursiop team, including CEO Brad Goldstein, believes that with additional development further significant gains will be achieved.

"Our patent-pending technology is based on a fundamental change in the way the coils are designed and manufactured," said Goldstein. "We at Tursiop are excited to be at the nexus of medical imaging and nanotechnology and look forward to providing clinicians the means to enhance the diagnosis and treatment of some of the major health concerns of our time, including heart disease, neurological disorders, and cancer."

JumpStart Entrepreneur-in-Residence Kevin Mendelsohn will be working with the company. "MRI scanners and coils are mature technologies that have experienced only incremental change over the past 10 to 15 years," Mendelsohn said. "Currently, the most effective method of improving image quality is through increased magnet strength, which is a costly alternative. The other is through the use of specialty coils, but when compared to increased magnet strength, the improvement has been relatively small. Tursiop's coils offer improved imaging performance comparable to that of a more powerful scanner, but at a much lower cost," he concluded.

With the close of this investment round, Tursiop plans to establish office and laboratory spaces, continue research and product development, and begin the FDA approval process.

This is JumpStart's 41st investment in its 30th company. Other healthcare companies in JumpStart's portfolio include AcelleRX Therapeutics, AnalizaDx, CardioInsight Technologies, CerviLenz, Great Lakes Pharmaceuticals, Synapse Biomedical and Telerad Express.

About Tursiop Technologies, LLC

Tursiop Technologies is developing revolutionary MRI coil devices utilizing proprietary nanotechnology, which will produce higher image quality and faster scan times resulting in a significant boost of the functional capabilities of any installed MRI system. Tursiop-generated imaging enhancements will apply across the entire range of MRI system field strengths, from low-field to high-field systems. Increased diagnostic competency will lead to improved patient outcomes and open the doors to new therapeutic opportunities within the areas of interventional, intra-operative and functional MRI and molecular imaging.

About RMS Management

RMS Management is an integrated family office that was formed in 1991 and is comprised of a diverse group of individuals and institutions providing financial and personal services to the founding families of a publicly traded real estate company. The company strives to enhance the professional and personal goals and objectives of every generation of the Ratner, Miller and Shafran families.

About JumpStart Inc.

JumpStart ( http://www.jumpstartinc.org ) accelerates the growth of innovative early-stage businesses and ideas into venture-ready companies by delivering vital, focused resources to entrepreneurs and the community of Northeast Ohio. JumpStart identifies and invests in early-stage companies that have strong potential in the marketplace, solid prospects for high growth, and are likely to qualify for later-stage funding. Beyond investing, the JumpStart team provides a continuum of business development services to its client companies to help ensure their success.


'/>"/>
SOURCE JumpStart Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. JIC Invests in Three New Alternative Energy Projects
2. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
3. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
4. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
5. The PLSG Invests $115,000 in Innovention Technologies, LLC
6. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
7. Applied Computational Technologies Appoints a New CEO
8. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
9. Senesco Technologies to Present at BIO 2008 Business Forum
10. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
11. Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
Breaking Biology Technology:
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Biology News(10 mins):